The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical and genomic characterization of metastatic small cell/neuroendocrine prostate cancer (SCNC) and intermediate atypical prostate cancer (IAC): Results from the SU2C/PCF/AACRWest Coast Prostate Cancer Dream Team (WCDT).
 
Eric Jay Small
No Relationships to Disclose
 
Rahul Raj Aggarwal
No Relationships to Disclose
 
Jiaoti Huang
No Relationships to Disclose
 
Artem Sokolov
No Relationships to Disclose
 
Li Zhang
No Relationships to Disclose
 
Joshi J. Alumkal
Research Funding - Aragon Pharmaceuticals (Inst); Astellas Pharma (Inst); Millennium (Inst); Novartis (Inst)
 
Jack Youngren
No Relationships to Disclose
 
Charles J. Ryan
Honoraria - Astellas Pharma; Janssen Oncology
Consulting or Advisory Role - Bayer; Millennium
Research Funding - BIND Biosciences; Karyopharm Therapeutics; Novartis
 
Adam Foye
No Relationships to Disclose
 
Robert Evan Reiter
Stock and Other Ownership Interests - Inanovate
Consulting or Advisory Role - Astellas Pharma
Patents, Royalties, Other Intellectual Property - patents surrounding discovery of PSCA and N-cadherin, owned by UCLA (Inst)
 
Christopher P. Evans
Stock and Other Ownership Interests - Medivation; Oncogenex
Honoraria - Janssen Oncology; Medivation; Sanofi
Consulting or Advisory Role - Janssen Oncology; Medivation; Millennium
Speakers' Bureau - Janssen Oncology; Medivation; Sanofi
Research Funding - Medivation
Travel, Accommodations, Expenses - Astellas Pharma; Janssen Oncology; Medivation; Sanofi
 
Martin Gleave
Employment - OncoGenex
Stock and Other Ownership Interests - OncoGenex
Honoraria - Astellas Pharma; Janssen
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Janssen; Oncogenex
Speakers' Bureau - Astellas Pharma; Janssen
Research Funding - Astellas Pharma; Janssen
Travel, Accommodations, Expenses - Amgen
 
Owen Witte
No Relationships to Disclose
 
Josh Stuart
No Relationships to Disclose
 
Theodore C. Goldstein
No Relationships to Disclose
 
George V. Thomas
No Relationships to Disclose
 
Lawrence D. True
No Relationships to Disclose
 
Himisha Beltran
Consulting or Advisory Role - Bayer
Research Funding - Astellas Pharma (Inst); Janssen (Inst); Lilly (Inst); Millennium (Inst)
 
Mark A. Rubin
No Relationships to Disclose
 
Tomasz M. Beer
Stock and Other Ownership Interests - Salarius Pharmaceuticals
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Dendreon; Janssen; Novartis
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Janssen Research & Development (Inst); Medivation (Inst); OncoGenex (Inst); Sotio; Sotio (Inst)